Axon Enterprise, Inc $AXON Stake Cut by Fifth Third Bancorp

Fifth Third Bancorp decreased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 1.5% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,303,883 shares of the biotechnology company’s stock after selling 19,612 shares during the period. Axon Enterprise makes up approximately 0.9% of Fifth Third Bancorp’s investment portfolio, making the stock its 18th largest holding. Fifth Third Bancorp’s holdings in Axon Enterprise were worth $550,917,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Axon Enterprise by 122,993.6% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company’s stock worth $195,036,000 after purchasing an additional 461,226 shares in the last quarter. B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Axon Enterprise during the 2nd quarter worth $3,854,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of Axon Enterprise during the 1st quarter worth $15,067,000. Brown Lisle Cummings Inc. grew its stake in shares of Axon Enterprise by 97,231.4% during the 2nd quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company’s stock worth $19,098,000 after purchasing an additional 34,031 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. increased its holdings in shares of Axon Enterprise by 40.7% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock valued at $6,406,000 after purchasing an additional 4,360 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

More Axon Enterprise News

Here’s some of the latest news about AXON:

Analyst Ratings Changes

Several brokerages recently commented on AXON. Piper Sandler reiterated an “overweight” rating and issued a $540.00 price objective (down from $561.00) on shares of Axon Enterprise in a research note on Friday, November 6th. Morgan Stanley boosted their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. TD Cowen lowered their target price on shares of Axon Enterprise from $825.00 to $800.00 and set a “buy” rating on the stock in a research report on Monday, October 26th. Raymond James Financial set a $675.00 target price on shares of Axon Enterprise in a research report on Thursday, October 15th. Finally, Needham & Company LLC dropped their target price on shares of Axon Enterprise from $750.00 to $500.00 and set a “buy” rating for the company in a report on Friday, November 6th. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $612.18.

Read Our Latest Stock Report on Axon Enterprise

Insider Buying and Selling at Axon Enterprise

In related news, insider Isaiah Fields sold 1,017 shares of the stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the sale, the insider directly owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. This represents a 1.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the sale, the chief executive officer directly owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. The trade was a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,397 shares of company stock valued at $21,234,034 over the last 90 days. 4.20% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Up 4.3%

AXON opened at $315.42 on Thursday. The business’s fifty day moving average is $426.24 and its two-hundred day moving average is $470.65. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.60 and a current ratio of 3.00. The company has a market cap of $25.68 billion, a price-to-earnings ratio of 101.10, a PEG ratio of 5.75 and a beta of 1.48. Axon Enterprise, Inc has a one year low of $291.45 and a one year high of $665.07.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm had revenue of $908.55 million during the quarter, compared to analysts’ expectations of $934.33 million. During the same quarter in the prior year, the business earned $1.17 EPS. The company’s quarterly revenue was up 27.8% compared to the same quarter last year. Analysts anticipate that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.